nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Allogeneic stem cell transplantation in MDS: How? When?
|
Platzbecker, Uwe |
|
2013 |
26 |
4 |
p. 421-429 9 p. |
artikel |
2 |
Chronic myelomonocytic leukemia: Myelodysplastic or myeloproliferative?
|
Itzkson, Raphael |
|
2013 |
26 |
4 |
p. 387-400 14 p. |
artikel |
3 |
Deletion 5q MDS: Molecular and therapeutic implications
|
Komrokji, Rami S. |
|
2013 |
26 |
4 |
p. 365-375 11 p. |
artikel |
4 |
Editorial Board / Aims & Scope
|
|
|
2013 |
26 |
4 |
p. iii- 1 p. |
artikel |
5 |
Erythropoiesis stimulating agents and other growth factors in low-risk MDS
|
Hellström-Lindberg, Eva |
|
2013 |
26 |
4 |
p. 401-410 10 p. |
artikel |
6 |
Hypomethylating agents and chemotherapy in MDS
|
Adès, Lionel |
|
2013 |
26 |
4 |
p. 411-419 9 p. |
artikel |
7 |
Index
|
|
|
2013 |
26 |
4 |
p. I- 1 p. |
artikel |
8 |
Morphology, cytogenetics and classification of MDS
|
Giagounidis, Aristoteles |
|
2013 |
26 |
4 |
p. 337-353 17 p. |
artikel |
9 |
Myelodysplastic Syndromes (MDS) and autoimmune disorders (AD): Cause or consequence?
|
Braun, Thorsten |
|
2013 |
26 |
4 |
p. 327-336 10 p. |
artikel |
10 |
Myelodysplastic syndromes: State of the art pathology, diagnosis and management
|
Fenaux, Pierre |
|
2013 |
26 |
4 |
p. 307-308 2 p. |
artikel |
11 |
Occupational and environmental etiology of MDS
|
Bowen, David T. |
|
2013 |
26 |
4 |
p. 319-326 8 p. |
artikel |
12 |
Refractory anemia with ring sideroblasts
|
Malcovati, Luca |
|
2013 |
26 |
4 |
p. 377-385 9 p. |
artikel |
13 |
Somatic mutations and epigenetic abnormalities in myelodysplastic syndromes
|
Itzykson, Raphael |
|
2013 |
26 |
4 |
p. 355-364 10 p. |
artikel |
14 |
The evolving challenge of therapy-related myeloid neoplasms
|
Churpek, Jane E. |
|
2013 |
26 |
4 |
p. 309-317 9 p. |
artikel |
15 |
When is iron overload deleterious, and when and how should iron chelation therapy be administered in myelodysplastic syndromes?
|
Steensma, David P. |
|
2013 |
26 |
4 |
p. 431-444 14 p. |
artikel |